Invasive aspergillosis: Clinical features of 35 proven cases at a single institution

Medicine

Volumn 77, Issue 3, 1998, Pages 188-194

  Kaiser, Laurent ^a   Huguenin, Tatiana ^a   Lew, P Daniel ^a   Chapuis, Bernard ^a   Pittet, Didier ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; CYCLOSPORIN; ITRACONAZOLE; LYMPHOCYTE ANTIBODY; PREDNISONE; STEROID;

ADULT; AGED; ASPERGILLOSIS; ASPERGILLUS; BLOOD DISEASE; BONE MARROW TRANSPLANTATION; CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL FEATURE; EARLY DIAGNOSIS; FEMALE; HIGH RISK PATIENT; HISTOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY DIAGNOSIS; MALE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SOLID TUMOR; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS; FEMALE; HOSPITALIZATION; HUMANS; LACTAMS; LENGTH OF STAY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SPUTUM; STEROIDS; TIME FACTORS;

EID: 0031839367     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005792-199805000-00004     Document Type: Review

References (46)

1. Aisner J, Murillo J, Schimpff SC, Steere A. Invasive aspergillosis in acute leukemia: Correlation with nose cultures and antibiotic use. Ann Intern Med 90: 4-9, 1979.
2. Albelda SM, Talbot GH, Gerson SL, Miller WT, Cassileth PA. Role of fiberoptic bronchoscopy in the diagnosis of invasive pulmonary aspergillosis in patients with acute leukemia. Am J Med 76: 1027-34, 1984.
3. Anaissie E. Opportunistic mycoses in the immunocompromised host: Experience at a cancer center and review. Clin Infect Dis 14(Suppl 1): S43-S53, 1992.
4. Arnow PM, Andersen RL, Mainous PD, Smith EJ. Pulmonary aspergillosis during hospital renovation. Am Rev Respir Dis 118: 49-53, 1978.
5. Beyer J, Schwartz S, Heinemann V, Siegert W. Strategies in prevention of invasive pulmonary aspergillosis in immunosuppressed or neutropenic patients. Antimicrob Agents Chemother 38: 911-17, 1994.
6. Bodey G, Bueltmann B, Duguid W, Gibbs D, Hanak H, Hotchi M, Mall G, Martino P, Meunier F, Milllken S. Fungal infections in cancer patients: An international autopsy survey. Eur J Clin Microbiol Infect Dis 11:99-109, 1992.
7. Caillot D, Casasnovas O, Bernard A, Couaillier J, Durand C, Cuisenier B, Solary E, Piard F, Petrella T, Bonnin A, Couillault G, Dumas M, Guy H. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol 15: 139-47, 1997.
8. Cowie F, Meller ST, Cushing P, Pinkerton R. Chemoprophylaxis for pulmonary aspergillosis during intensive chemotherapy. Arch Dis Child 70: 136-38, 1994.
9. Denning DW, Lee JY, Hostetler JS, Pappas P, Kauffman CA, Dewsnup DH, Galgiani JN, Graybill JR, Sugar AM, Catanzaro A, et al. NIAID Mycoses Study Group multicenter trial of oral itraconazole therapy for invasive aspergillosis. Am J Med 97: 135-44, 1994.
10. Denning DW, Stevens DA. Antifungal and surgical treatment of invasive aspergillosis: Review of 2,121 published cases. Rev Infect Dis 12: 1147-1201, 1990.
11. Fisher BD, Armstrong D, Yu B, Gold JWM. Invasive aspergillosis. Am J Med 71: 571-80, 1981.
12. Gefter W. The spectrum of pulmonary aspergillosis. J Thorac Imaging 7: 56-74, 1992.
13. Gefter WB, Albelda SM, Talbot GH, Gerson SL, Cassileth PA, Miller W. Invasive pulmonary aspergillosis and acute leukemia. Limitations in the diagnostic utility of the air crescent sign. Radiology 157: 605-10, 1985.
14. Gerson SL, Talbot GH, Hurwitz S, Strom BL, Lusk EJ, Cassileth P. Prolonged granulocytopenia: The major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Ann Intern Med 100: 345-51, 1984.
15. Guiot HFL, Fibbe WE, van't Wout JW. Risk factors for fungal infection in patients with malignant hematologic disorders: Implications for empirical therapy and prophylaxis. Clin Infect Dis 18: 525-32, 1994.
16. Gustafson TL, Schaffner W, Lavely GB, Stratton CW, Johnson HK, Hutcheson RHJ. Invasive aspergillosis in renal transplant recipients: Correlation with corticosteroid therapy. J Infect Dis 148: 230-40, 1983.
17. Hofflin JM, Potasman I, Baldwin JC, Oyer PE, Stinson EB, Remington JS. Infectious complications in heart transplant recipients receiving cyclosporine and corticosteroids. Ann Intern Med 106: 209-16, 1987.
18. Iwen PC, Reed EC, Armitage JO, Bierman PJ, Kessinger A, Vose JM, Arneson MA, Winfield BA, Woods G. Nosocomial invasive aspergillosis in lymphoma patients treated with bone marrow or peripheral stem cell transplants. Infect Control Hosp Epidemiol 14: 131-39, 1993.
19. Janssen J, Strack van Schijndel R, Van der Poest Clement E, Ossenkippele G, Thijs L, Huijgens P. Outcome of ICU treatment in invasive aspergillosis. Intensive Care Med 22: 1315-22, 1996.
20. Kahn FW, Jones JM, England DM. The role of bronchoalveolar lavage in the diagnosis of invasive pulmonary aspergillosis. Am J Clin Pathol 86: 518-23, 1986.
21. Kurup VP, Kumar A. Immunodiagnosis of aspergillosis. Clin Microbiol Rev 4: 439-56, 1991.
22. Levy H, Horak DA, Tegtmeier BR, Yokota SB, Forman S. The value of bronchoalveolar lavage and bronchial washings in the diagnosis of invasive pulmonary aspergillosis. Respir Med 86: 243-48, 1992.
23. Loundon KW, Burnie JP, Coke AP, Matthews RC. Application of polymerase chain reaction to fingerprinting Aspergillus fumigatus by random amplification of polymorphic DNA. J Clin Microbiol 31: 1117-21, 1993.
24. McWhinney PH, Kibbler CC, Hamon MD, Smith OP, Gandhi L, Berger L, Walesby RK, Hoffbrand AV, Prentice H. Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: 13 years' experience. Clin Infect Dis 17: 397-404, 1993.
25. Mills W, Chopra R, Linch DC, Goldstone AH. Liposomal amphotericin B in the treatment of fungal infections in neutropenic patients: A single-center experience of 133 episodes in 116 patients. Br J Haematol 754-60, 1994.
26. Morrison VA, Haake RJ, Weisdorf D. The spectrum of non-Candida fungal infections following bone marrow transplantation. Medicine (Baltimore) 72: 78-89, 1993.
27. Nakamura H, Shibata Y, Kudo Y, Saito S, Kimura H, Tomoike H. [Detection of Aspergillus fumigatus DNA by polymerase chain reaction in the clinical samples from individuals with pulmonary aspergillosis.] Rinsho Byori 42: 676-81, 1994.
28. Opal SM, Asp AA, Cannady PB Jr, Morse PL, Burton LI, Hammer PG. Efficacy of infection control measures during a nosocomial outbreak of disseminated aspergillosis associated with hospital construction. J Infect Dis 153: 634-37, 1986.
29. Orr DP, Myerowitz RL, Dubois PJ. Patho-radiologic correlation of invasive pulmonary aspergillosis in the compromised host. Cancer 41: 2028-35, 1978.
30. Pai U, Blinkhorn RJ Jr, Tomashefski JF. Invasive cavitary pulmonary aspergillosis in patients with cancer: A clinicopathologic study. Hum Pathol 25: 293-303, 1994.
31. Palmer LB, Greenberg HE, Schiff M. Corticosteroid treatment as a risk factor for invasive aspergillosis in patients with lung disease. Thorax 46: 15-20, 1991.
32. Pannuti C, Gingrich R, Pfaller MA, Kao C, Wenzel R. Nosocomial pneumonia in patients having bone marrow transplant. Attributable mortality and risk factors. Cancer 69: 2653-62, 1992.
33. Pittet D, Huguenin T, Dharan S, Sztajzel-Boissard J, Ducel G, Thorens J-B, Auckenthaler R, Chevrolet J-C. Unusual cause of lethal pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 154: 541-44, 1996.
34. Ribrag V, Dreyfus F, Venot A, Leblong V, Lanore JJ, Varet B. Prognostic factors of invasive pulmonary aspergillosis in leukemic patients. Leuk Lymphoma 10: 317-21, 1993.
35. Richard C, Romon I, Baro J, Insunza A, Loyola I, Zurbano F, Tapia M, Iriondo A, Conde E, Zubizarreta A. Invasive pulmonary aspergillosis prior to BMT in acute leukemia patients does not predict a poor outcome. Bone Marrow Transplant 12: 237-41, 1993.
36. Ringden O, Meunier F, Tollemar J, Ricci P, Tura S, Kuse E, Viviani MA, Gorin NC, Klastersky J, Fenaux P, et al. Efficacy of amphotericin B encapsulated in liposomes (AmBisome) in the treatment of invasive fungal infections in immunocompromised patients. J Antimicrob Chemother 28(Suppl B): 73-82, 1991.
37. Saito H, Anaissie EJ, Morice RC, Dekmezian R, Bodey GP. Bronchoalveolar lavage in the diagnosis of pulmonary infiltrates in patients with acute leukemia. Chest 94: 745-49, 1988.
38. Saugier Veber P, Devergie A, Sulahian A, Ribaud P, Traore F, Bourdeau Esperou H, Gluckman E, Derouin F. Epidemiology and diagnosis of invasive pulmonary aspergillosis in bone marrow transplant patients: Results of a 5 year retrospective study. Bone Marrow Transplant 12: 121-24, 1993.
39. Sherertz RJ, Belani A, Kramer BS, Elfenbein GJ, Weiner RS, Sullivan ML, Thomas RG, Samsa G. Impact of air filtration on nosocomial Aspergillus infections. Unique risk of bone marrow transplant recipients. Am J Med 83: 709-18, 1987.
40. Spreadbury C, Holden D, Aufauvre-Brown A, Bainbridge B, Cohen J. Detection of Aspergillus fumigatus by polymerase chain reaction. J Clin Microbiol 31: 615-21, 1993.
41. Stevens DA, Lee JY. Analysis of compassionate use itraconazole therapy for invasive aspergillosis by the NIAID mycoses study group criteria. Arch Intern Med 157: 1857-62, 1997.
42. Vogeser M, Hass A, Aust D, Ruckdeschel G. Postmortem analysis of invasive aspergillosis in a tertiary care hospital. Eur J Clin Microbiol Infect Dis 16: 1-16, 1997.
43. Wingard JR, Beals SU, Santos GW, Merz WG, Saral R. Aspergillus infections in bone marrow transplant recipients. Bone Marrow Transplant 2: 175-81, 1987.
44. Winston DJ, Gale RP, Meyer DV, Young LS, and the UCLA Bone Marrow Transplantation Group. Infectious complications of human bone marrow transplantation. Medicine (Baltimore) 58: 1-31, 1979.
45. Yamakami Y, Hashimoto A, Tokimastsu I, Nasu M. PCR detection of DNA specific for Aspergillus species in serum of patients with invasive aspergillosis. J Clin Microbiol 34: 2464-68, 1996.
46. Young RC, Bennett JE, Vogel CL, Carbone PP, DeVita VT. Aspergillosis. The spectrum of the disease in 98 patients. Medicine (Baltimore) 49: 147-73, 1970.